Search Results for keywords:"Confidential Information"

The Small Business Administration (SBA) has announced changes to its Risk Rating System, an internal tool used to evaluate the risk of its loan operations and portfolios of 7(a) Lenders and Certified Development Companies. These updates involve improving the model that determines the loan risk ratings and updating the Lender Portal to ensure it reflects current data and economic conditions. The changes aim to enhance prediction accuracy and transparency while allowing the SBA to efficiently manage lender oversight and performance assessment. The public is invited to comment on these updates.

The National Heart, Lung, and Blood Institute, part of the National Institutes of Health, has announced a closed meeting for the Heart, Lung, and Blood Initial Review Group to discuss grant applications. This virtual meeting, scheduled for February 20-21, 2025, from 9:00 a.m. to 12:00 p.m., will review applications that may involve confidential information, including trade secrets or personal data. Because of this sensitive content, the meeting will not be open to the public. For more information, Fungai Chanetsa, the Scientific Review Officer, can be contacted at the provided details.

The National Institute of Neurological Disorders and Stroke has announced several closed meetings to review grant applications and cooperative agreement applications. These meetings, set to take place in early 2025, will be closed to the public due to the potential disclosure of confidential information and personal privacy concerns. The meetings will be held at the Sheraton New Orleans and the National Institutes of Health's Neuroscience Center, with options for in-person and virtual attendance. Meetings will address topics such as analgesic discovery and digital endpoints as part of the HEAL Initiative.

The National Institutes of Health announced several closed meetings in April 2025 to review and evaluate grant applications. These virtual meetings will gather different committees, such as the Oncology Basic Translational Integrated Review Group and the Cardiovascular and Respiratory Sciences Integrated Review Group, among others. The discussions will be closed to the public to protect confidential information, including trade secrets and personal data. The meetings are conducted under the Federal Advisory Committee Act's provisions, with specific contact persons listed for further inquiries.

The document is a notice from the National Institutes of Health announcing several closed meetings organized by the Center for Scientific Review. These meetings are set to occur between March 16 and March 18, 2021, and are focused on evaluating various grant applications related to different scientific fields. The agenda for each meeting is to review and assess these applications, and the closed status is to prevent disclosure of sensitive information such as patentable materials and private personal details. The notice includes details about the committees involved, the dates, times, and how to contact the corresponding Scientific Review Officers.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. The meeting is scheduled for March 4, 2025, and will be held via video conference. The purpose of this meeting is to review and evaluate grant applications related to Occupational Safety and Health Training Project Grants. Due to the potential disclosure of confidential or personal information, the meeting will not be open to the public.

Notice is given of upcoming meetings for the National Human Genome Research Institute's Special Emphasis Panels, which will be closed to the public. These meetings will review and evaluate grant applications and are scheduled for April 4, 2025, with one focusing on SBIR—STTR and the other on Ethical, Legal, and Social Implications. The discussions could involve confidential or personal information, necessitating privacy. The meetings will be held virtually or video-assisted, and interested individuals can contact the specified NIH officials for more details.

The National Institute on Aging is holding a closed meeting on February 14, 2025, from 10:00 a.m. to 3:00 p.m. to review and evaluate grant applications. This meeting, focused on Alzheimer's Disease and Alzheimer's Disease-Related Dementias research in low and middle-income countries, will be conducted virtually. Due to the confidential nature of the material, including trade secrets and personal information, the meeting will not be open to the public. For further inquiries, Dr. Thomas John O'Farrell is the contact person at the National Institute on Aging.

The Centers for Disease Control and Prevention (CDC) announced a closed meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel. This meeting, scheduled for May 25-26, 2021, will review and evaluate grant applications related to preventing violence and violence-related injuries. It will be held via videoconference, and is closed to the public to protect confidential information and personal privacy associated with the grant applications. The details were signed by Kalwant Smagh, who has the authority to manage such announcements for the CDC.

The National Cancer Institute announced a series of meetings that will be closed to the public according to the Federal Advisory Committee Act. These meetings, scheduled for April 10-11, 2025, will focus on reviewing grant applications and are closed to prevent the disclosure of confidential information. The review sessions will take place virtually and will evaluate proposals, including potentially sensitive commercial or personal details. Interested parties may contact Jeffrey E. DeClue for further information.